Prasterone (Intrarosa) for Dyspareunia (Reprinted from The Medical Letter on Drugs and Therapeutics vol 59, pg 149-150, 2017)

被引：0

作者：

Abramowicz, Mark

Zuccotti, Gianna

Pflomm, Jean-Marie

机构：

来源：

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION | 2017年 / 318卷 / 16期

关键词：

VULVO-VAGINAL ATROPHY; DEHYDROEPIANDROSTERONE; SYMPTOMS;

D O I：

10.1001/jama.2017.14981

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：1607 / 1608

页数：2

共 12 条

[1]

ABRAMOWICZ M, 2017, MED LETT DRUGS THERP, V59, P149

[2]

[Anonymous], MED LETT DRUGS THER

[3] Comparison of intravaginal 6.5 mg (0.50%) prasterone, 0.3 mg conjugated estrogens and 10 μg estradiol on symptoms of vulvovaginal atrophy [J].

Archer, David F. ;

Labrie, Fernand ;

Montesino, Marlene ;

Martel, Celine .

JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY, 2017, 174 :1-8

[4] Treatment of pain at sexual activity (dyspareunia) with intravaginal dehydroepiandrosterone (prasterone) [J].

Archer, David F. ;

Labrie, Fernand ;

Bouchard, Celine ;

Portman, David J. ;

Koltun, William ;

Cusan, Leonello ;

labrie, ClauDe ;

Cote, Isabelle ;

Lavoie, Lyne ;

Martel, Celine ;

Balser, John .

MENOPAUSE-THE JOURNAL OF THE NORTH AMERICAN MENOPAUSE SOCIETY, 2015, 22 (09) :950-963

[5] Biological aspects and candidate biomarkers for psychotic bipolar disorder: A systematic review [J].

Buoli, Massimiliano ;

Caldiroli, Alice ;

Melter, Claudia Cumerlato ;

Serati, Marta ;

de Nijs, Jessica ;

Altamura, A. Carlo .

PSYCHIATRY AND CLINICAL NEUROSCIENCES, 2016, 70 (06) :227-244

[6]

Constantine GD, 2015, MENOPAUSE, V22, P36, DOI [10.1097/GME.0000000000000275, 10.1097/gme.0000000000000275]

[7] Breast cancer, endometrial cancer, and cardiovascular events in participants who used vaginal estrogen in the Women's Health Initiative Observational Study [J].

Crandall, Carolyn J. ;

Hovey, Kathleen M. ;

Andrews, Christopher A. ;

Chlebowski, Rowan T. ;

Stefanick, Marcia L. ;

Lane, Dorothy S. ;

Shifren, Jan ;

Chen, Chu ;

Kaunitz, Andrew M. ;

Cauley, Jane A. ;

Manson, JoAnn E. .

MENOPAUSE-THE JOURNAL OF THE NORTH AMERICAN MENOPAUSE SOCIETY, 2018, 25 (01) :11-20

[8] Vulvar and Vaginal Atrophy in Postmenopausal Women: Findings from the REVIVE (REal Women's VIews of Treatment Options for Menopausal Vaginal ChangEs) Survey [J].

Kingsberg, Sheryl A. ;

Wysocki, Susan ;

Magnus, Leslie ;

Krychman, Michael L. .

JOURNAL OF SEXUAL MEDICINE, 2013, 10 (07) :1790-1799

[9] Efficacy of intravaginal dehydroepiandrosterone (DHEA) on moderate to severe dyspareunia and vaginal dryness, symptoms of vulvovaginal atrophy, and of the genitourinary syndrome of menopause [J].

Labrie, Fernand ;

Archer, David F. ;

Koltun, William ;

Vachon, Andree ;

Young, Douglas ;

Frenette, Louise ;

Portman, David ;

Montesino, Marlene ;

Cote, Isabelle ;

Parent, Julie ;

Lavoie, Lyne ;

Beauregard, Adam ;

Martel, Celine ;

Vaillancourt, Mario ;

Balser, John ;

Moyneur, Erick .

MENOPAUSE-THE JOURNAL OF THE NORTH AMERICAN MENOPAUSE SOCIETY, 2016, 23 (03) :243-256

[10] Prasterone has parallel beneficial effects on the main symptoms of vulvovaginal atrophy: 52-week open-label study [J].

Labrie, Fernand ;

Archer, David F. ;

Bouchard, Celine ;

Girard, Ginette ;

Ayotte, Normand ;

Gallagher, John C. ;

Cusan, Leonello ;

Baron, Mira ;

Blouin, Francois ;

Waldbaum, Arthur S. ;

Koltun, William ;

Portman, David J. ;

Cote, Isabelle ;

Lavoie, Lyne ;

Beauregard, Adam ;

Labrie, Claude ;

Martel, Celine ;

Balser, John ;

Moyneur, Erick .

MATURITAS, 2015, 81 (01) :46-56

← 1 2 →